id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2286538,d7770ffc-e2ff-418d-9434-8d570c4c7f56,Q1,"JOHNSON & JOHNSON SERVICES, INC.",20686,JOHNSON & JOHNSON SERVICES INC,2019,first_quarter,TRD,"-Issues related to the NAFTA/USMCA renegotiation issues.
-Issues related to new tariff proclamations and retaliation.","HOUSE OF REPRESENTATIVES,SENATE,White House Office",,1440000,0,0,2019-04-22T14:26:16.577000-04:00
2286539,d7770ffc-e2ff-418d-9434-8d570c4c7f56,Q1,"JOHNSON & JOHNSON SERVICES, INC.",20686,JOHNSON & JOHNSON SERVICES INC,2019,first_quarter,TAX,"- Issues related to miscellaneous tax bills.
- Issues related to spending and linked to corporate tax rate
- H.R.1711/S.780 - No Tax Breaks for Outsourcing Act, regarding all provisions
- H.R.1712/S.779 - Stop Tax Haven Abuse Act, regarding all provisions
- Issues related to replacing G1LT1 global average method with a per country minimum.
- Issues related to CFC look through.
- Issues related to the Tax Cut and Jobs Act of 2017
- H.R. 1922/S. 1089 - A bill to amend the Internal Revenue Code of 1986 to repeal the amendments made by the Patient Protection and Affordable Care Act which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangements, regarding all provisions.","HOUSE OF REPRESENTATIVES,SENATE,White House Office",,1440000,0,0,2019-04-22T14:26:16.577000-04:00
2286540,d7770ffc-e2ff-418d-9434-8d570c4c7f56,Q1,"JOHNSON & JOHNSON SERVICES, INC.",20686,JOHNSON & JOHNSON SERVICES INC,2019,first_quarter,HCR,"- H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions
- S. 726 - Personal Care Products Safety Act, regarding all provisions
- H.R. 269 - Pandemic and All-Hazards Preparedness & Advancing Innovation Act of 2019, regarding all provisions
- Issues related to the reputation of over-the-counter drugs
- Issues related to cosmetic regulatory reform
- Issues related to cosmetic animal testing
- Issues related to biosimilars
- Issues related to maternal mortality
- Issues related to contact lens safety
- Issues related to the medical device tax repeal
- Issues related to medical product communications
- Issues related to medical product review
- Issues related to talc safety
- Issues related to drug pricing reform
- Issues related to diversity in clinical trials
- Issues related to health care pricing transparency
- Issues related to peripheral artery disease","HOUSE OF REPRESENTATIVES,SENATE,White House Office",,1440000,0,0,2019-04-22T14:26:16.577000-04:00
2286541,d7770ffc-e2ff-418d-9434-8d570c4c7f56,Q1,"JOHNSON & JOHNSON SERVICES, INC.",20686,JOHNSON & JOHNSON SERVICES INC,2019,first_quarter,VET,"-Issues regarding Healthy Heroes, partnership with the VA on Suicide Prevention, integrated marketing, clinical trials and personalized medicine.
-Issues related to VA medical device procurement issues.","HOUSE OF REPRESENTATIVES,SENATE,White House Office",,1440000,0,0,2019-04-22T14:26:16.577000-04:00
2286542,d7770ffc-e2ff-418d-9434-8d570c4c7f56,Q1,"JOHNSON & JOHNSON SERVICES, INC.",20686,JOHNSON & JOHNSON SERVICES INC,2019,first_quarter,MMM,- Issues related to reimbursement,"HOUSE OF REPRESENTATIVES,SENATE,White House Office",,1440000,0,0,2019-04-22T14:26:16.577000-04:00
2286543,d7770ffc-e2ff-418d-9434-8d570c4c7f56,Q1,"JOHNSON & JOHNSON SERVICES, INC.",20686,JOHNSON & JOHNSON SERVICES INC,2019,first_quarter,BUD,"-Issues related to FY2020 Appropriations, specifically the Special Olympics, The Global Fund, Food & Drug Administration, Commerce, Interior, and Environmental Protection Agency budgets.","HOUSE OF REPRESENTATIVES,SENATE,White House Office",,1440000,0,0,2019-04-22T14:26:16.577000-04:00
2286544,d7770ffc-e2ff-418d-9434-8d570c4c7f56,Q1,"JOHNSON & JOHNSON SERVICES, INC.",20686,JOHNSON & JOHNSON SERVICES INC,2019,first_quarter,CPT,"- Patent Trade Office reforms
- H.R.1520-Purple Book Continuity Act of 2019, regarding all provisions
- H.R.1503-Orange Book Transparency Act of 2019, regarding all provisions
- H.R.1499-Protecting Consumer Access to Generic Drugs Act of 2019, regarding all provisions
- S.649 -Biologic Patent Transparency Act, regarding all provisions.","HOUSE OF REPRESENTATIVES,SENATE,White House Office",,1440000,0,0,2019-04-22T14:26:16.577000-04:00
2286545,d7770ffc-e2ff-418d-9434-8d570c4c7f56,Q1,"JOHNSON & JOHNSON SERVICES, INC.",20686,JOHNSON & JOHNSON SERVICES INC,2019,first_quarter,ENV,"- H.R. 1834 - Defending our National Marine Sanctuaries from Damaging Chemicals Act of 2019, regarding all provisions","HOUSE OF REPRESENTATIVES,SENATE,White House Office",,1440000,0,0,2019-04-22T14:26:16.577000-04:00
2286546,d7770ffc-e2ff-418d-9434-8d570c4c7f56,Q1,"JOHNSON & JOHNSON SERVICES, INC.",20686,JOHNSON & JOHNSON SERVICES INC,2019,first_quarter,TOR,- Issues related to civil justice reform.,"HOUSE OF REPRESENTATIVES,SENATE,White House Office",,1440000,0,0,2019-04-22T14:26:16.577000-04:00